Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria

This study is currently recruiting participants.

See

Contacts and Locations

Verified November 2016 by Michael Devera, MD, Loma Linda University

Sponsor:

ClinicalTrials.gov Identifier:

NCT01141478

First Posted: June 10, 2010

Last Update Posted: November 4, 2016

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Information provided by (Responsible Party):

Michael Devera, MD, Loma Linda University

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2018
Estimated Primary Completion Date:	June 2017 (Final data collection date for primary outcome measure)

Study Status:

This study is currently recruiting participants.

Estimated Study Completion Date:

June 2018

Estimated Primary Completion Date:

June 2017 (Final data collection date for primary outcome measure)